Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Baloise explores sale of $1.1 billion Belgian insurance portfolio – sources

Published 11/29/2023, 09:30 AM
Updated 11/29/2023, 11:15 AM
© Reuters.

By Pablo Mayo Cerqueiro

LONDON (Reuters) - Swiss insurer Baloise is in talks to sell around 1 billion euros ($1.1 billion) of life insurance policies in Belgium, two people familiar with the matter told Reuters.

The Basel-based group has been working with bankers at ING Groep (AS:INGA) to gauge interest in the portfolio, said the people, who spoke on condition of anonymity.

Discussions are at an advanced stage, and a deal could be signed soon, one of the people added.

"It is standard procedure for us to regularly review parts of our portfolios in the country units," a Baloise spokesperson said, declining to comment further. "Should this result in changes, we would communicate them at the appropriate time."

ING declined to comment.

The efforts come as other traditional insurers sell non-core portfolios with a view to freeing up capital held against those liabilities.

In April, Dutch insurer Aegon (NYSE:AEG) sold its UK individual protection portfolio to rival Royal London.

Baloise had previously looked to acquisitions to grow its business in Belgium.

In 2020, the Swiss group purchased the non-life insurance operations of Apollo-backed Athora. The year before, it acquired multiline insurer Fidea.

Baloise saw premiums in its non-life insurance business grow by close to 6% in the first nine months of the year to 3.4 billion Swiss francs ($3.9 billion) globally.

However, life insurance premiums dropped more than 4% to 2.9 billion francs during the same period, according to its latest earnings release.

($1 = 0.9100 euros)

($1 = 0.8760 Swiss francs)

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.